Ed Arce

Stock Analyst at WestPark Capital

(4.19)
# 492
Out of 5,044 analysts
471
Total ratings
46.37%
Success rate
16.7%
Average return

Stocks Rated by Ed Arce

Enanta Pharmaceuticals
Sep 30, 2025
Maintains: Buy
Price Target: $24$28
Current: $10.44
Upside: +168.20%
Travere Therapeutics
Jun 11, 2025
Assumes: Buy
Price Target: $30
Current: $29.81
Upside: +0.64%
MetaVia
Apr 16, 2025
Reiterates: Buy
Price Target: $12
Current: $0.97
Upside: +1,136.99%
Unicycive Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $75
Current: $4.72
Upside: +1,488.98%
Arcturus Therapeutics Holdings
Apr 10, 2025
Reiterates: Buy
Price Target: $60
Current: $9.88
Upside: +507.29%
Akebia Therapeutics
Apr 4, 2025
Reiterates: Buy
Price Target: $7.5
Current: $3.09
Upside: +142.72%
Inventiva
Apr 2, 2025
Reiterates: Buy
Price Target: $13
Current: $5.27
Upside: +146.68%
Galectin Therapeutics
Apr 2, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.09
Upside: -
Talphera
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $1.30
Upside: +361.54%
Aligos Therapeutics
Mar 31, 2025
Reiterates: Buy
Price Target: $70
Current: $9.24
Upside: +657.58%
Reiterates: Neutral
Price Target: n/a
Current: $30.89
Upside: -
Reiterates: Buy
Price Target: $240
Current: $6.30
Upside: +3,709.52%
Reiterates: Neutral
Price Target: n/a
Current: $1.78
Upside: -
Reiterates: Buy
Price Target: $32
Current: $8.24
Upside: +288.35%
Maintains: Buy
Price Target: $24$35
Current: $105.14
Upside: -66.71%
Maintains: Buy
Price Target: $72$75
Current: $54.00
Upside: +38.89%
Reiterates: Buy
Price Target: $29$21
Current: $14.84
Upside: +41.56%
Maintains: Buy
Price Target: $66$72
Current: $70.22
Upside: +2.53%
Maintains: Buy
Price Target: $400$405
Current: $429.18
Upside: -5.63%
Reiterates: Neutral
Price Target: $5.5
Current: $5.11
Upside: +7.74%
Reiterates: Buy
Price Target: $95
Current: $34.77
Upside: +173.22%
Reiterates: Buy
Price Target: $13
Current: $4.20
Upside: +209.52%
Reiterates: Buy
Price Target: $5
Current: $4.58
Upside: +9.17%
Reiterates: Buy
Price Target: $48
Current: $36.14
Upside: +32.82%
Reiterates: Neutral
Price Target: $7.5
Current: $8.55
Upside: -12.28%
Reiterates: Buy
Price Target: $5
Current: $0.66
Upside: +654.15%
Reiterates: Buy
Price Target: $13
Current: $12.64
Upside: +2.85%
Upgrades: Neutral
Price Target: n/a
Current: $1.81
Upside: -
Reiterates: Buy
Price Target: $25
Current: $29.94
Upside: -16.49%
Downgrades: Neutral
Price Target: n/a
Current: $1.47
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $19.23
Upside: -
Assumes: Buy
Price Target: $7
Current: $34.93
Upside: -79.96%
Initiates: Buy
Price Target: $21
Current: $35.44
Upside: -40.74%
Downgrades: Neutral
Price Target: n/a
Current: $3.21
Upside: -